Leptin in human physiology and therapeutics.

Leptin in human physiology and therapeutics.
复制标题

DOI:
10.1016/j.yfrne.2010.06.002
复制
发表时间:
2010-07
影响因子:
7.4
通讯作者:
Mantzoros, Christos S.
Mantzoros, Christos S.
中科院分区:
医学1区
文献类型:
--
作者:
Dardeno, Tina A.;Chou, Sharon H.;Moon, Hyun-Seuk;Chamberland, John P.;Fiorenza, Christina G.;Mantzoros, Christos S.

文献摘要

参考文献

被引文献

相似文献

瘦素调节能量平衡和生殖、神经内分泌、免疫和代谢功能。在这篇综述中,我们描述了瘦素在人体生理学中的作用,并回顾了最近的“概念验证”临床试验的证据,使用重组人瘦素与先天性瘦素缺乏症,低瘦素血症与能量缺乏状态,高瘦素血症与花园品种肥胖症。由于大多数肥胖个体在很大程度上是瘦素耐受或抵抗的,瘦素的治疗用途目前仅限于完全或部分瘦素缺乏的患者,包括下丘脑性闭经和脂肪萎缩。在这些能量缺乏状态下给予瘦素可能有助于恢复相关的神经内分泌、代谢和免疫功能以及骨代谢。瘦素治疗目前可用于患有先天性瘦素缺乏和先天性脂肪萎缩的个体。瘦素治疗下丘脑性闭经和获得性脂肪萎缩的长期疗效和安全性目前正在研究中。瘦素和潜在的瘦素增敏剂的联合治疗是否能有效治疗普通肥胖症,以及瘦素是否能在维持减肥中发挥作用,都是值得期待的。
Leptin regulates energy homeostasis and reproductive, neuroendocrine, immune, and metabolic functions. In this review, we describe the role of leptin in human physiology and review evidence from recent “proof of concept” clinical trials using recombinant human leptin in subjects with congenital leptin deficiency, hypoleptinemia associated with energy-deficient states, and hyperleptinemia associated with garden-variety obesity. Since most obese individuals are largely leptin-tolerant or -resistant, therapeutic uses of leptin are currently limited to patients with complete or partial leptin deficiency, including hypothalamic amenorrhea and lipoatrophy. Leptin administration in these energy-deficient states may help restore associated neuroendocrine, metabolic, and immune function and bone metabolism. Leptin treatment is currently available for individuals with congenital leptin deficiency and congenital lipoatrophy. The long-term efficacy and safety of leptin treatment in hypothalamic amenorrhea and acquired lipoatrophy are currently under investigation. Whether combination therapy with leptin and potential leptin sensitizers will prove effective in the treatment of garden-variety obesity and whether leptin may have a role in weight loss maintenance is being greatly anticipated.
DOI: 10.1359/jbmr.060705
发表时间: 2006-10-01
影响因子: 6.2
作者:
Baldock, Paul A.;Allison, Susan;Herzog, Herbert
通讯作者: Herzog, Herbert
DOI: 10.1007/s001250050722
发表时间: 1997-05-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Berti, L;Kellerer, M;Haring, HU
通讯作者: Haring, HU
DOI: 10.1038/oby.2006.317
发表时间: 2006-08-01
期刊: OBESITY
影响因子: 6.9
作者:
Ahima, Rexford S.
通讯作者: Ahima, Rexford S.
DOI: 10.1210/en.140.6.2755
发表时间: 1999-06-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Ahima, RS;Bjorbæk, C;Flier, JS
通讯作者: Flier, JS
DOI: 10.1073/pnas.95.11.6061
发表时间: 1998-05-26
影响因子: 11.1
作者:
Carpenter, LR;Farruggella, TJ;Stahl, N
通讯作者: Stahl, N